Jubilant Pharmova has been issued a show cause notice by tax authorities in Mysore for GST liabilities totaling Rs 87.31 crore for the fiscal year 2022-2023. The demand includes tax, interest, and penalties related to Input Tax Credit discrepancies. The company has formally contested the claims, describing the notice as legally and factually incorrect, and expects no material impact on its operations.
Jubilant Pharmova Challenges Rs 87 Crore Tax Demand
Total Demand: Rs 87.31 crore (GST, Interest, and Penalties)
Fiscal Year: 2022-2023
Reader Takeaway: Management is contesting the GST demand as factually incorrect and expects no material financial or operational impact.
What just happened
Jubilant Pharmova Limited has received a show cause notice from the Assistant Commissioner of Commercial Taxes in Mysore regarding its GST liabilities for the 2022-2023 financial year. The total demand amount specified in the filing is Rs 87.31 crore. This figure comprises Rs 33.58 crore in GST tax, Rs 20.15 crore in interest, and a penalty of Rs 33.58 crore.
Why this matters
For investors, tax-related notices involving significant sums often trigger concerns regarding potential cash outflows and regulatory friction. The notice specifically alleges issues concerning ineligible Input Tax Credit (ITC), excess ITC claims, and discrepancies found when comparing tax filings against E-waybill records. However, the company has clarified its intent to vigorously defend its position, which provides some assurance to shareholders that this is not an admission of liability.
Company Response and Outlook
Management has responded firmly, categorizing the notice as "factually and legally incorrect" and "bad in law." The company asserts that the tax authorities failed to verify the facts properly or provide an adequate opportunity for the firm to represent its side before issuing the notice. Jubilant Pharmova is currently preparing a detailed reply to be filed with the tax department and anticipates no adverse impact on its financial stability or day-to-day business operations.
Risks to watch
While the company currently expects a favorable resolution, tax litigations can be time-consuming. Any further escalation by the tax department, such as an order confirming the demand, could lead to a temporary cash outflow or further legal costs. Investors should track the subsequent filings for updates on the department's response to the company’s rebuttal.